Objectives: To determine relative effects of diets high in synthetic sources of myristic (14:0), palmitic (16:0) or stearic (18:0) acid on concentrations and metabolism of serum lipoproteins. Design: Eighteen healthy women participated in a three-way cross-over study for ®ve week periods separated by seven week washout periods, diets were assigned in random order. Subjects: Premenopausal women, not on medication, were from three races (Caucasian, African-American, Asian) and four apolipoprotein E phenotype groups (3a3, 3a2, 4a3, and 4a2). Intervention: During the ®rst week the subjects consumed a baseline diet providing 11 energy (en)% saturated fat, 10 en% polyunsaturated fat and 14 en% monounsaturated fat. Followed by test diets with 19 en% saturated fat (including 14 en% test saturated fatty acid), 3 en% polyunsaturated fat, and 14 en% monounsaturated fat for four weeks. Synthetic fats (trimyristin, tripalmitin, and tristearin) were used in blends with natural fats and oils. Results: Mean concentrations of serum total, esteri®ed and LDL cholesterol were signi®cantly lower after 18:0 than after 16:0 (n 16 ± 18, P`0.01 for treatment effect). Myristic acid (14:0) had an intermediate effect.
Introduction
Structured triglycerides are molecules having fatty acids rearranged on the glycerol molecule in a random or purposeful fashion (Haumann, 1997) . Currently, there is considerable interest in development of structured triglycerides which may have unique physiological properties and special uses in patient populations (Bell et al, 1997) . Formulation and development of speci®c structured triglyceride for special purposes requires knowledge of the metabolic properties of individual fatty acids. These properties may or may not be extrapolated from studies of the effects of the fatty acids provided in natural fats or oils.
From data obtained from studies of natural fats and oils, Hegsted et al (1965) developed multiple regression equations predicting that myristic acid (14:0) is more hypercholesterolemic than lauric (12:0) and palmitic acids (16:0) while stearic acid (18:0) and medium chain fatty acids, similar to oleic acid, a monounsaturated fatty acid (18:1), are essentially neutral. Subsequent human studies with natural sources of triglyceride (Kris-Etherton et al, 1993; Tholstrup et al, 1994a) supported the idea that 12:0 14:0 and 16:0 but not 18:0 are the hypercholesterolemic fatty acids. There has also been an indication that 16:0, under certain conditions, is not as detrimental as 12:0 and 14:0 (Sundrum et al, 1994) . However, we (Wardlaw et al, 1995) reported that a structured lipid made up of theoretically neutral medium chain fatty acids (8:0 10:0) and a poorly digested long chain saturated fatty acid (behenic acid, 22:0) had an effect on serum low density lipoprotein cholesterol (LDL-C) concentration similar to that of natural fats high in myristic and palmitic (butter) and lauric, myristic and palmitic acids (palm kernel oil palm oil) suggesting that current concepts about the relative cholesterolemic properties of the saturated fatty acids are more complicated than previously believed.
Myristic acid, often considered the most cholesterolemic saturated fatty acid in both human and animal studies (Hegsted et al, 1995; Hayes & Khosla, 1992) , is not the major saturated fatty acid in any commonly consumed natural fat or oil (USDA, 1979) . One must feed a synthetic triglyceride to obtain a diet in which myristate is the major saturated fatty acid. Results of human feeding studies involving a high myristic or palmitic acid synthetic fat suggested that myristic acid either was not more cholesterolemic than palmitic acid (Tholstrup et al, 1994a) or produced, on average, about 4% higher levels of LDL-C (Zock et al, 1994) . A synthetic high lauric acid oil raised plasma LDL cholesterol concentrations less than did a natural source of palmitic acid (Denke & Grundy, 1992) .
A diet high in a synthetic source of stearic acid reduced plasma total cholesterol 14% compared to a diet high in a natural source of palmitic acid (Bonanome & Grundy, 1988) . In a stable isotope study with ethyl esters of palmitic, myristic and stearic acid, which were fed to ®ve men, Hughes et al (1996) concluded that the three saturated fatty acids are metabolized differently in the postprandial state. It is important to investigate the effects of different fatty acids on various aspects of lipoprotein metabolism in humans as well as animal models.
The objective of this study was to investigate the cholesterolemic and metabolic effects of two saturated fatty acids, 14:0 and 16:0 (believed to be cholesterolemic by most if not all researchers) and 18:0 (generally believed to be neutral). A high (13 ± 14 en%) level of one of the three saturated fatty acids was fed in each test diet while levels of other individual saturated fatty acids were held below 3 en%. A large portion of each test saturated fatty acids was furnished by structured triglycerides that provided the test fatty acid in all positions on the glycerol molecule.
Methods

Subjects
Eighteen healthy premenopausal women were initially enrolled in this three-period cross-over study, the minimum number needed to detect a mean difference for serum lipoprotein levels between treatments of about 10% with a standard deviation of approximately 8% and a power of 0.9. The subjects were not taking medication known to in¯uence lipoprotein metabolism, including oral contraceptives. Subjects who completed at least two study periods were 19 ± 43 y of age (mean AE s.e.m. 28 AE 1.5) and weighed between 50 and 77 kg. The subjects' weight (paired-t analysis) did not change signi®cantly during the study. According to results of a 7 d activity recall (Blair et al, 1985) daily energy expenditure was between 7.7 and 12.9 MJ. Mean AE s.e.m. serum cholesterol concentration at screening was 4.62 AE 0.25 mmoles L 71 , range 3.18 ± 6.54 mmoles L
71
. Ethnic background was Caucasian, 12; African-American, 2; and Asian, 4. The subjects had the following apolipoprotein E phenotypes: apoE 3a3, 10; apoE 3a2, 4, apoE 4a3, 3 and apoE 4a2, 1. Prior to starting this study, subjects signed a consent form approved by the Ohio State University Biomedical Human Studies Committee. Two subjects left the study at the end of the ®rst period; one of these was replaced by her sister, who had an identical apoE phenotype (3a2) and very similar baseline lipoprotein concentrations. The other subject was not replaced, and her data were not used. An alternate, added during the last two periods, followed the rotation designated for the subject who left. Two other subjects left the study at the end of the second period and were not replaced.
Design
The eighteen subjects were randomized into three groups using a three-period and six-sequence design (363 crossover design) except that only 17 subjects consumed the myristic acid diet and only 16 consumed the palmitic acid diet for reasons described above. For standardization purposes the subjects consumed a baseline diet higher in polyunsaturated fat and lower in saturated fat (Table 1) for the ®rst week of each period. According to results of a previous study, serum lipoprotein concentrations respond strongly to substitution of a high polyunsaturated fat diet for a saturated diet or subjects' usual diet within one week (Snook et al, 1985) . One of the high saturated fat diets was given during the subsequent four weeks. There were washout periods of seven weeks between treatments so that blood samples at baseline and at the end of the experimental period were always obtained at the same stage of each subject's menstrual cycle.
Blood samples were obtained by venipuncture after an overnight fast two times during the last three days of the baseline period and twice during the last three days of each feeding period; data were averaged. Depending on the requirements of the procedure, analyses commenced immediately or serum, obtained by centrifugation (5006g for 20 min), was frozen at 7 80 C for later analysis.
Diets
The diets were prepared in a metabolic kitchen in the Department of Human Nutrition and Food Management. On weekdays subjects ate breakfast and dinner in the metabolic dining room and took out a sack lunch. Except for Saturday night dinner, which was served in the metabolic unit, subjects took out weekend meals. The baseline diet provided 40 en% total fat, 10 en% 18:2, 14 en% 18:1, 11 en% saturated fat, and about 327 mg cholesterol per day ( Table 1 ). The three experimental diets were formulated to . The smaller amounts of tristearin and tripalmitin compared to trimyristin used in the fat blends re¯ected the higher availability of these fatty acids in natural oils and the dif®culties we encountered in preparing acceptable food products with these structured fats. At least 20% of each test saturated fatty acid was provided in the sn-2 position of the triglyceride. The fat blends were incorporated into cakes and cookies, used as fat spreads on bread, and added to the main dishes at dinner. A basal menu providing 8.3 MJ (about 2000 kcal) was given initially. Subjects requiring more calories to maintain body weight (as determined by daily weighing) were given extra cakes and cookies made up of fat blends with the same proportion of fatty acids as the overall diet. Adjustments over 1.2 MJ were met by altering menus to furnish additional protein, fat, and carbohydrate.
Daily records of the subjects' food intakes were kept and analyzed using Food Processor II software (ESHA Research, Salem, OR) with added data on fatty acid composition of the foods in the menu (Table 1) . Composites of the rotating four day menus were made and analyzed for speci®c fatty acid composition by gas liquid chromatography (Table 1) .
Digestibility of dietary fatty acids
To assess apparent digestibility of dietary fatty acids, we administered 50 mg Brilliant Blue before breakfast and then again three days later during the fourth week of each period. Feces collected between the appearance of the two markers were composited, mixed thoroughly with a known amount of water, and stored at 7 20 C until fatty acid analysis.
Serum lipoprotein concentrations
Previously frozen serum samples were analyzed for total cholesterol (TC) and free cholesterol by an enzymatic assay (Allain et al, 1974) . Total HDL-, HDL 2 -and HDL 3 -C were determined by the same enzymatic procedure after precipitation of apoprotein B-containing lipoproteins with dextran sulfate-Mg 2 solution and then removal of HDL 2 with a stronger dextran sulfate-Mg 2 solution (Warnick et al, 1982) . LDL-cholesterol (in mg dL
71
) was calculated as TC minus (HDL-C plus 0.2 triglycerides). Results for the two pre-and post-period analyses were averaged and converted to mmoles L
. Serum from a previously frozen sample pool was analyzed with each analysis for TC. The precision (CV) of the sequenced runs of this pool was 2.7%. A turbimetric procedure (Raichem, San Diego, California, USA) was used to assay serum apolipoproteins A-1 and B in one pre-and one post-period blood sample that had been stored at 7 80 C.
LDL receptor activity LDL binding to and degradation via LDL receptors in freshly isolated mononuclear cells (MNC) was determined using methods described in detail previously (Ho et al, 1976; Kuo et al, 1989; Park et al, 1996) . Brie¯y, iodinated LDL (McFarlane, 1958) was prepared within 3 d prior to each major blood draw using pooled blood obtained from a constant group of donors who consumed self-selected diets. We assumed the composition of the donor LDL remained constant throughout the study, but this was not speci®cally assessed. For measurement of LDL degradation and binding, MNC were isolated by centrifugation (8006g for 20 min at room temperature) from saline-diluted whole blood anticoagulated with sodium citrate and overlayered with Nycoprep TM washed and counted. Degradation of 125 I-LDL by MNC was assessed by incubating cell samples with 125 I-LDL (20 mg mL 71 ) in the presence and absence of 20-fold excess of unlabeled LDL at 37 C for 5 h, a period previously shown to be suitable for demonstrating differences among treatments. Nonspeci®c and speci®c degradation represented, respectively, degradation in the presence of 20-fold excess unlabeled LDL and the difference between the latter and degradation in the absence of excess unlabeled LDL. For determination of speci®c and nonspeci®c binding of LDL, MNC were incubated for one hour at 4 C with 5, 10, 20 and 40 and 80 mg mL 71 125 I-LDL in the presence and absence of excess unlabeled LDL.
Cholesterol biosynthesis in MNC
The rate of cholesterol biosynthesis by MNC was determined as described by McNamara et al (1985) . Brie¯y, MNC were incubated with 2.5 mM (2-14 C) acetate (DuPont NEN) and autologous serum obtained at the time of the test at 37
C for 4 h in a metabolic shaker. The reaction was terminated by adding 5 M KOH. An internal standard (1,2-3 H cholesterol) and the reaction mixture were saponi®ed by heating. Nonsaponifed lipids were extracted with hexane and applied to a column of aluminum oxide. The eluted (acetone:diethyl ether) sterol fraction was reduced in volume and counted in a scintillation counter.
Endogenous cholesterol esteri®cation and transfer
The isotopic method of Channon et al (1990) was used to measure endogenous cholesterol esteri®cation (lecithincholesterol acyl transferase (LCAT) activity) and transfer (cholesterol ester transfer protein (CETP) activity) in serum. Brie¯y, for determination of esteri®cation rate, fresh serum was preincubated at 4
C for 1 h with 3 Hcholesterol-albumin emulsion; after equilibration of added and endogenous cholesterol, the mixture was incubated at 37 C for 3 h. Lipids were extracted, separated by thin layer chromatography, and radioactivity of cholesterol ester and free cholesterol spots counted by liquid scintillation. For cholesterol transfer activity, transfer of radiolabeled cholesterol ester into VLDL and LDL was measured ®rst by precipitating the two apoB-containing lipoproteins from the incubate with dextran sulfate. Then, total radioactivity in the incubate, in the HDL-containing supernatant, and in the apoprotein B-containing lipids was measured by liquid scintillation counting. These data were used to calculate the rate of transfer of the cholesterol ester.
Effect of synthetic triglycerides on serum lipoprotein metabolism JT Snook et al Apolipoprotein E phenotype Apo E phenotype was determined by isoelectrofocusing of delipidated plasma followed by immunoblotting using polyclonal goat anti-human apo E antiserum as ®rst antibody and rabbit antiserum to goat IgG as second antibody according to the method of Kamboh et al (1988) and as adapted for use in our laboratory by Park et al (1996) and Tso et al (1998) .
Fatty acid analysis
Fatty acid composition of food composites, feces, and red blood cell membranes, isolated by the method of Fraga et al (1990) was determined as described previously (Sukija & Palmquist, 1988) .
Statistical analyses
The baseline and end of period values and mean differences between the beginning and the end of each period were analyzed statistically. Differences between baseline and experimental values were analyzed by paired-t test in which individual subjects served as their own controls. Differences among the three experimental diets, of which the main differences were the three saturated fatty acid combinations, were analyzed using a linear model which contained terms for the subjects, periods, direct treatments and carry-over effects and adjusted for missing data. The models were ®tted using PROC MIXED in the Statistical Analysis System (SAS) program, Cary, North Carolina, USA. Signi®cance level was set at a 0.05. Means which were signi®cantly different among diets were separated in the linear model by PROC MIXED. Treatment effects were adjusted for any signi®cant effects of other variables in the model including carry over effects and period effects. Relationships among dependent variables were determined by correlation analysis.
Results
Diet composition and apparent availability of dietary fatty acids
The experimental saturated fatty acid diets provided similar amounts of dietary cholesterol and poly-and mono-unsaturated fat (Table 1) , differing only in amount of 14:0, 16:0 or 18:0. Each experimental diet contained approximately equal amounts of test saturated fatty acid (28 ± 31 g) and 18:1 (31 ± 35 g). The baseline diet provided three times as much 18:2 as the experimental diets and only about half as much saturated fatty acid (Table 1 ). The composition of the baseline diet and the experimental diets was not typical of fatty acid availability in the USA food supply. The baseline diet was higher in polyunsaturated fat and lower in saturated fat than typical USA diets (Marston & Raper, 1987) while the myristic acid diet furnished about 20 times more 14:0, the palmitic acid diet about four times more 16:0 and the stearic acid diet about eight times more 18:0 acid than typically consumed (Cresanta et al, 1988) .
Apparent absorption of the test fatty acids depended on chain length and saturation. The mean AE s.e.m. apparent excretion of 18:0 by subjects fed the stearic acid diet was 14.1 AE 2.3% (Table 2) although one subject excreted 33.5%; one, 29%; and ®ve others, about 20%. The other subjects excreted less than 10% of the ingested dose. The 18:0 was not well absorbed (11.1 AE 1.6% and 11.3 AE 2.1% excretion) from the 14:0 and 16:0 diets, respectively. On average, only about 5.3 AE 1.0% of the 16:0 in the palmitic acid diet was excreted while the other dietary fatty acids usually were well absorbed (`3% excreted). However, the 9.2 AE 1.6% excretion of 14:0 was higher (P`0.05) on the stearic acid diet than on the myristic acid and palmitic acid diets.
Serum lipoprotein concentrations
There was a signi®cant (P`0.05) independent effect of the saturated fat diets on serum concentrations of TC and LDL-C and on their changes from baseline values. At the end of the four week treatment periods, the 14:0 and 16:0 diets raised (P`0.05) mean serum total cholesterol concentrations above baseline values whereas 18:0 had no effect (Table 3) . Postperiod values for total cholesterol were Values within a row are different (P 0.000). Effect of synthetic triglycerides on serum lipoprotein metabolism JT Snook et al higher for 14:0 and 16:0 than 18:0 (P 0.001 for treatment effect), but effects produced by 14:0 and 16:0 were not different (P 0.36). Mean concentrations of serum LDL-C were higher on 16:0 than on 18:0 (P 0.002) at the end of the treatment periods. Individuals varied considerably in their response to the three high saturated fat diets (Figure 1) . For example, when 14:0 replaced the baseline diet, three subjects had relatively large increases in LDL-C, while the remaining 14 subjects had modest increases or decreases. On the 16:0 diet, six subjects had strong increases in LDL-C while the other 10 subjects who ate this diet had only small changes (Figure 1) . Nine subjects had modest increases in LDL-C on the stearic acid diet while the other nine had decreases in LDL-C (Figure 1 ). All four of the subjects with an apo E4 allele had strong responses to the high 16:0 diet, but apo E phenotype was not a factor in the response to the 14:0 and 18:0 diets in this study. Furthermore, subjects who were strong responders to one diet were not necessarily strong responders to the other experimental diets.
There was no independent effect of dietary treatment on serum concentrations of total triglycerides, HDL-C and HDL 2 -C, but HDL 3 -C decreased (P`0.05) when 18:0 was fed (Table 3) . Mean serum concentrations of apolipoprotein B and A-1 were not altered by the saturated fat diets although changes in apoB and LDL-C were weakly correlated (r 0.3, P 0.03) while changes in apo A-1 and HDL 3 -C were also weakly associated (r 0.29, P 0.037).
Changes in variables related to cholesterol esteri®cation and transfer in serum
As with serum LDL-C, there was a signi®cant (P 0.025) independent effect of dietary treatment on concentrations of cholesterol ester, which were lower after four weeks on the 18:0 diet than on the 16:0 diet. Consumption of high 16:0 but not 14:0 or 18:0 also produced a signi®cant increase in cholesterol ester compared to baseline (Table 4) . Serum samples from the subjects were incubated in vitro to study rates of cholesterol esteri®cation and transfer to apoB containing lipoproteins. These reactions are part of the reverse cholesterol transfer process and result in remodeling of HDL and other lipoproteins in serum. The rate of cholesterol esteri®cation (LCAT activity) declined on the 18:0 diet compared to baseline but was not altered signi®cantly by 14:0 and 16:0. The rate of cholesterol ester transfer (CETP activity) from HDL to triglyceride-rich lipoproteins increased on all of the experimental diets. In the data set analyzed as a whole, changes in LDL-C and CETP activity were weakly correlated (r 0.29, P 0.038) as were postperiod values for CETP activity and LDL-C concentrations (r 0.46, P 0.0006) and total HDL-C (r 7 0.34, P 0.015).
Changes in cholesterol biosynthesis and LDL receptor activity in MNC
Freshly isolated mononuclear cells (MNC) obtained from the subjects before and after they consumed the treatment diets were used as a model system to study cholesterol biosynthesis and LDL degradation in vitro. The rate of cholesterol biosynthesis in MNC was not affected (P b 0.05) by the dietary treatments (Table 5 ). In the statistical analysis of the entire subject group, there was a signi®cant treatment (P 0.05) effect on the rate of receptor mediated 125 I-LDL degradation which declined 35% from baseline when subjects were fed 16:0 but did not change signi®cantly compared to baseline in the other experimental groups (Table 5) . At the end of the experimental period, receptor-mediated degradation was higher on 14:0 than on the 16:0 treatment. Nonspeci®c or nonreceptor mediated degradation of 125 I-LDL was higher (P 0.03) on the 16:0 treatment than on 14:0 and 18:0.
The effects of the treatments on the ability of LDL to bind to LDL receptors in MNC were inconclusive partly because the preperiod values for receptor mediated LDL binding were the only preperiod values to differ signi®-cantly (P 0.03) among baseline periods in this study. In general, the postperiod values for binding and the changes in receptor mediated binding from baseline suggested a negative effect of 14:0 and 16:0 and a positive effect of 18:0 (P`0.06) on the ability of the subjects' MNC LDL to bind donor (not their own) LDL. Results of Scatchard analysis (Table 5) Effect of synthetic triglycerides on serum lipoprotein metabolism JT Snook et al increased on 18:0. However, the data were variable, the changes were less than 10%, and there was no signi®cant treatment effect.
Red blood cell membrane fatty acid composition
We analyzed red blood cell samples for fatty acid composition during the last two periods of this study but not the ®rst. The only fatty acid to change signi®cantly in red blood cell (RBC) membranes between baseline and the end of the experimental period was myristic acid when the high 14:0 diet was fed. Membrane 14:0 increased from 0.72 AE 0.42% to 1.39 AE 0.12% of total identi®ed fatty acids, (n 11, P`0.02) on the myristic acid diet whereas 14:0 in RBC membranes declined to below 0.5% on the other two diets.
There was an insigni®cant (P b 0.05) increase in 18:1 from 14.93 AE 0.62% of total identi®ed fatty acids to 17.17 AE 1.16% (n 11, P`0.10) when the high 18:0 diet was fed. This increase was not signi®cantly different (P b 0.05) from the one observed on diets high in 14:0 (from 15.87 AE 0.59% to 16.62 AE 0.66%) and 16:0 (16.9 AE 0.59 to 18.18 AE 1.29%).
Discussion
In this comparison of three diets providing large amounts (14 en%) of commonly consumed saturated fatty acids Ð myristic, palmitic or stearic acid Ð we observed that palmitic acid, in contrast to stearic acid, produced higher serum concentrations of TC, LDL-C and cholesterol ester and lower receptor-mediated degradation of LDL in an in vitro assay involving MNC of the human subjects enrolled in the study. In our study design, myristic acid was not more cholesterolemic than palmitic acid. This was the ®rst time, to our knowledge, that diets high in each of the three saturated fatty acids, provided largely as synthetic triglycerides, were compared in the same human study. Another unique aspect of this human study is that we investigated several metabolic or genetic variables, in addition to serum lipoprotein concentrations, to try to explain some of the metabolic effects of the three fatty acids.
Effects on serum lipoprotein concentrations
Our results agreed with previous work with natural fats and oils (Hegsted et al, 1965; Kris-Etherton et al, 1993; Tholstrup et al, 1994b) in which diets very high in stearic acid ( b 10 en%) produced lower serum concentrations of LDL-C than diets high in 12:0 14:0, 14:0 16:0, or 16:0. Multiple regression analysis of data from investigations of natural fats and oils suggested 14:0 is the most cholesterolemic saturated fatty acid (Hegsted et al, 1965; Mensink & Katan, 1992) , but, despite the statistical associations, myristic acid (14:0) is not the major saturated fatty acid in any commonly consumed natural products including butter, meat, and tropical oils (USDA, 1979) , and diets high in myristic acid are even higher in lauric or palmitic acid. Previous research involving the feeding of a synthetic 14:0 diet indicated that mean LDL-C concentration on 14:0 and 16:0 (fed in synthetic form) were not different (Tholstrup et al, 1994a) or that mean LDL-C was about 4% or 0.11 mmolaL higher (P`0.0086) on 14:0 than on 16:0 fed as palm oil (Zock et al, 1994) . In this study myristic acid seemed less cholesterolemic in contrast to palmitic acid than in many previous studies. In this study the effects of 14:0 and 16:0 on LDL-C concentrations were not different but the mean change in LDL-C produced by 14:0 was 5% above baseline values while 16:0 produced a 15% increase in mean concentration of LDL-C. However, there was considerable variation among participants in the cholesterolemic response to the different diets.
The concept of respondersanonresponders to hypercholesterolemic diets is not new (Ginsberg et al, 1981; McNamara et al, 1987; Glatz et al, 1993) . According to Glatz et al (1993) variations in response may be partly random in nature and partly due to metabolic differences among subjects. Three of the six subjects with strong responses to the 16:0 diet had the apoE 4a3 phenotype; another was the apoE 4a2 subject. The remaining two were apo E3a3. ApoE phenotype was not associated with a particular cholesterolemic response to the diets high in 14:0 and 18:0. Previously, we reported that according to multiple regression analysis, variations in the LDL-C response to diets high in synthetic 14:0, 16:0 and 18:0 may be determined, at least in part, by apoE polymorphism (Tso et al, 1998) . For example, 35% of the variance in changes in serum LDL-C concentrations was explained by eating the diet with 18:0 (negative or reducing association, partial R 2 0.18) and having apoE 4a3 phenotype (positive or enhancing association, partial R 2 0.18). We cannot exclude the possibility that myristic acid might be as cholesterolemic as palmitic acid or more so in subject populations lacking the apoE 4 isoform.
One difference between this study and previous ones involving synthetic fats is we fed trimyristin, tripalmitin or tristearin blended with natural sources of unsaturated and saturated fat while other investigators fed synthetic fats high in a speci®c saturated acid interesteri®ed with other fatty acids so that the majority of the fat molecules were not consumed in the form of trimyristin, tripalmitin and tris- (Kuksis, 1992) , but animal fats such as butter or lard have considerable 14:0 or 16:0, respectively, in this position, and the fatty acids would be expected to remain in the sn-2 position throughout the digestive process. Therefore, after the digestive process is complete, synthetic triglycerides of 14:0 or 16:0 may be a reasonable model for some animal fats. Tholstrup et al (1994a) speculated that myristic acid is hypercholesterolemic not because it is present in the sn-2 position as in milk fat but rather when it is fed in diets providing considerable lauric or palmitic acids such as diets high in coconut oil, palm kernel oil or butter. Our results are consistent with theory.
Stearic acid was not absorbed as well as myristic and palmitic acids, but the lower rate of absorption did not seem to account for the neutral cholesterolemic response Bonanome & Grundy (1988) explored two possible explanations for the failure of 18:0 to increase blood cholesterol concentrations compared to 16:0 Ð poor absorption of 18:0 and conversion of at least some of the 18:0 to 18:1 after absorption. In their study, 18:0 was absorbed as well as 16:0 (over 97%) but the relative percentage of 18:1 in plasma triglycerides and cholesteryl esters was about 15% higher on the 18:0 diet. In our study, the changes induced in serum LDL-C concentrations by the 14:0, 16:0 and 18:0 diets in a statistical analysis of the combined data were modestly correlated with the amount of 18:0 excreted in feces (r 7 0.31, P 0.034). Although malabsorption of 18:0 may have had an impact on the results, it is clear that other variables are involved. As regards conversion of 18:0 ± 18:1, Hughes et al (1996) in studying a deuterated stearate ethyl ester did not ®nd appreciable evidence of desaturation or elongation of stearate. This result was consistent with our data for red blood cell membrane 18:1.
Intravascular lipoprotein metabolism
The process of reverse cholesterol transport (RCT) involves HDL (in particular, a pre-beta migrating apoprotein apo A-1 HDL), transfer of free cholesterol from tissues to HDL, esteri®caton by LCAT, and either direct transfer to the liver or transfer to apoB-containing lipoproteins by cholesterol ester transfer protein (CETP) (Quintao, 1995) . Higher CETP activity associated with lower concentrations of plasma HDL-C, has been noted in patients with angiographically detectable coronary artery disease (Hibino et al, 1996) . Evidence from studies of humans with a genetic de®ciency of CETP and of transgenic mice expressing CETP suggest both atherogenic and antiatherogenic effects for the transfer protein (Tall, 1995; Bruce et al, 1998) . According to these researchers, CETP activity may result in lower serum HDL-C, a potential atherogenic effect. On the other hand, CETP activity may convert HDL to a form that is more able to participate in RCT, an antiatherogenic effect.
Several changes were noted in intravascular cholesterol remodeling in this study, but it would be dif®cult to speculate whether they were atherogenic or antiatherogenic. The saturated fat diets, in contrast to the polyunsaturated baseline diet, increased cholesterol ester transfer activity. This result is consistent with previous reports indicating the diets high in saturated fat increase CETP (Tall, 1995; Bruce et al, 1998) . In this study, higher CETP activity was weakly associated with lower HDL-C (r 7 0.34, P 0.02), and, interestingly, with lower HDL 3 -C (r 7 0.30, P 0.03), an HDL form more likely to participate in removal of tissue cholesterol. This overall effect seems to be atherogenic although there was no mean reduction of HDL in the treatment groups analyzed as a whole. Stearic acid was unique among the three test fatty acids in that it lowered mean concentrations of HDL 3 -C as well as LCAT activity, ®ndings somewhat indicative of reduced reverse cholesterol transport. Schwab et al (1996) reported that CETP activity was 12% higher after 16:0 compared to 18:0, a result consistent with ours.
Changes in CETP activity were weakly correlated with changes in LDL-C concentrations (r 0.29, P 0.038). This result supported the idea expressed by Fielding (1997) that LDL-C may increase in responders to dietary fat because of increases in CETP activity. However, because dietary treatment had an independent effect on LDL-C concentrations, but not on CETP activity, it appeared that increases in LDL-C preceded, rather than followed, changes in CETP activity. Synthesis of CETP may be regulated by the size of free cholesterol pools in cells, according to Bruce et al (1998) . Regulatory pools of cellular free cholesterol increase when more saturated fat diet is eaten (Woollet et al, 1992) . Possibly, these putative regulatory pools of free cholesterol are enlarged in subjects with a strong positive response to a saturated fat diet and this effect may enhance CETP synthesis.
Receptor-mediated LDL degradation in MNC Spady et al (1993) have stated that steady state concentrations of LDL-C in blood are largely a function of the rate of LDL-C production and the activity of the LDL-receptor. Woollett et al (1992) assessed the effect of saturated fatty acids ranging in chain length from 6:0 ± 18:0 which were provided as synthetic triglycerides on LDL receptor activity in hamsters by performing a primed continuous infusion of 125 I-LDL. The majority of the LDL was cleared by liver through receptor-mediated processes. These authors categorized the saturated fatty acids Ð 12:0, 14:0, and 16:0 Ð together in a group that reduced LDL-receptor activity to about the same degree when fed in cholesterol-containing diets. Stearic acid did not reduce LDL-receptor activity. We used an MNC model to study LDL receptor activity in an assay that assessed binding and degradation of 125 I-LDL in vitro. Changes in LDL receptor activity in MNC and in liver are coordinated, according to a study involving rabbits (Roach et al, 1993) . The LDL used in our human study was from a donor pool so its composition was constant and not a variable in the in vitro LDL receptor assay (Fernandez & McNamara, 1989) . Therefore, changes in MNC LDL receptor activity in this study should re¯ect the in¯uence of the dietary treatment on MNC receptor binding af®nity or number and not on the composition of the ligand.
In our model 14:0 and 18:0 did not alter LDL receptor activity in MNC compared to the baseline diet. However, receptor-mediated LDL degradation in MNC was 35% lower (P`0.05) on palmitic acid compared to the polyunsaturated baseline diet. Receptor-mediated LDL binding tended to be lower on both 14:0 and 16:0 than on 18:0 (P`0.06). The 9% insigni®cant decrease in Bmax sugEffect of synthetic triglycerides on serum lipoprotein metabolism JT Snook et al gested that the 35% decrease in receptor-mediated LDL degradation observed in MNC on the 16:0 diet was a function, at least in part, of changes in factors other than receptor number. According to Tso et al (1998) 33% of the variance in changes in receptor-mediated LDL degradation in MNC was explained by eating the high palmitic acid diet (negative association, partial R 2 0.16) and having the apoE 3a2 phenotype (positive association, partial R 2 0.17). More work is needed to determine more speci®cally if myristic and palmitic acids have different effects on LDL receptor function in other human tissues and how these activities relate to the overall fractional catabolism of LDL in vivo. Perhaps, as suggested by Spady et al (1993) , the results of short term human studies only indicate trends in lipid metabolism and not new steady state values, which take longer to establish in humans than in the hamster.
Conclusions
A high stearic acid diet, with a PaS ratio of about 0.2, had similar effects on serum lipoprotein levels and LDL receptor activity as a baseline diet with a PaS ratio of about 1 in this short term study. The 18:0 diet was low in 16:0, unlike a typical Western diet. The diet high in 16:0 reduced receptor-mediated LDL degradation in MNC more than did the 14:0 diet and tended to raise LDL-C concentrations more in study participants viewed as a whole, but individual responses may be mediated, in part, by having an apoE 4 phenotype. The effects of the three fatty acids, fed as synthetic triglycerides, were not particularly different from effects of natural fats and oils except for myristic acid, which was not as hypercholesterolemic as expected. These ®ndings suggest that the metabolic responses of humans to different saturated fats are complex and that some individuals will bene®t more than others from reducing saturated fat in the diet.
